FDA inspection
Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant): FDA inspection ending Mar 22, 2019
FDA inspection 1084107 · Voluntary Action Indicated (VAI) · Wenzhou
Key facts
| Inspection ID | 1084107 |
|---|---|
| Firm | Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) |
| FEI number | 3010728912 |
| Address | Economic & Technological Development Zon, NO. 555 the 8th Binhai Rd., Binhai Indus |
| City | Wenzhou |
| Country | China |
| Fiscal year | 2019 |
| Inspection end date | Mar 22, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data